Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
3D Simulations Capture the Persistent Low-Mode Asymmetries Evident in Laser-Direct-Drive Implosions on OMEGA.
Colaïtis A, Turnbull DP, Igumenschev IV, Edgell D, Shah RC, Mannion OM, Stoeckl C, Jacob-Perkins D, Shvydky A, Janezic R, Kalb A, Cao D, Forrest CJ, Kwiatkowski J, Regan S, Theobald W, Goncharov VN, Froula DH. Colaïtis A, et al. Among authors: kalb a. Phys Rev Lett. 2022 Aug 26;129(9):095001. doi: 10.1103/PhysRevLett.129.095001. Phys Rev Lett. 2022. PMID: 36083671
Butyrate supplementation in the liquid diet of dairy calves leads to a rapid recovery from diarrhea and reduces its occurrence and relapses in the preweaning period.
Nicola MS, Kalb AL, Barbosa AA, Velasquez BES, Rincon JAA, Feijó JO, Dellagostin EN, Martins AWS, Blödorn EB, Domingues WB, Lopes F, Quinteiro-Filho WM, Mondadori RG, Campos VF, Rabassa VR, Komninou ER, Delpino FAB, Corrêa MN. Nicola MS, et al. Among authors: kalb al. J Dairy Sci. 2023 Nov;106(11):7908-7923. doi: 10.3168/jds.2022-22670. Epub 2023 May 8. J Dairy Sci. 2023. PMID: 37164858 Free article.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial.
Köhler W, Engelen M, Eichler F, Lachmann R, Fatemi A, Sampson J, Salsano E, Gamez J, Molnar MJ, Pascual S, Rovira M, Vilà A, Pina G, Martín-Ugarte I, Mantilla A, Pizcueta P, Rodríguez-Pascau L, Traver E, Vilalta A, Pascual M, Martinell M, Meya U, Mochel F; ADVANCE Study Group. Köhler W, et al. Lancet Neurol. 2023 Feb;22(2):127-136. doi: 10.1016/S1474-4422(22)00495-1. Lancet Neurol. 2023. PMID: 36681445 Clinical Trial.
75 results